TransMedics (TMDX) Cash from Financing Activities (2018 - 2026)
TransMedics (TMDX) posted quarterly Cash from Financing Activities of $3.8 million for Q1 2026, up 24.24% year-over-year from $3.0 million in Q1 2025, and up 21.39% quarter-over-quarter from $3.1 million in Q4 2025.
TransMedics (TMDX) Cash from Financing Activities (2018 - 2026) Analysis & Trends
TransMedics' Cash from Financing Activities history runs 9 years deep, the most recent figure standing at $3.8 million for Q1 2026.
- In Q1 2026, Cash from Financing Activities rose 24.24% year-over-year to $3.8 million; the TTM figure through Mar 2026 stood at $17.6 million (down 22.56% YoY), while the FY2025 annual figure was $16.9 million, down 26.3% from the prior year.
- Cash from Financing Activities for Q1 2026 stood at $3.8 million, up from $3.1 million in the prior quarter.
- The five-year high for Cash from Financing Activities was $394.0 million in Q2 2023, with the low at $237000.0 in Q2 2022.
- The 5-year median for Cash from Financing Activities is $3.2 million (2024), against an average of $36.0 million.
- Peak annual rise in Cash from Financing Activities reached 166150.21% in 2023, while the deepest fall reached 99.07% in 2023.
- TransMedics' Cash from Financing Activities stood at $3.1 million in 2022, then tumbled by 69.85% to $924000.0 in 2023, then increased by 28.35% to $1.2 million in 2024, then surged by 161.3% to $3.1 million in 2025, then gained by 21.39% to $3.8 million in 2026.
- Business Quant data shows TMDX's Cash from Financing Activities at $3.8 million in Q1 2026, $3.1 million in Q4 2025, and $3.6 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.44 Bn | 193.84 Bn | 7.27 Bn | -3.52 Bn |
| 2 | Stryker | 127.32 Bn | 123.85 Bn | 4.50 Bn | -95.00 Mn |
| 3 | Medtronic | 118.87 Bn | 109.65 Bn | 6.41 Bn | -888.00 Mn |
| 4 | Boston Scientific | 73.47 Bn | 72.93 Bn | 3.85 Bn | -410.00 Mn |
| 5 | Edwards Lifesciences | 51.90 Bn | 47.65 Bn | 1.35 Bn | -300,000.00 |
| 6 | Dexcom | 34.30 Bn | 32.36 Bn | 830.00 Mn | -607.30 Mn |
| 7 | GE HealthCare Technologies | 33.74 Bn | 31.63 Bn | 2.18 Bn | -236.00 Mn |
| 8 | Koninklijke Philips | 26.35 Bn | 23.03 Bn | 4.55 Bn | -1.34 Bn |
| 9 | Steris | 23.05 Bn | 22.56 Bn | 684.20 Mn | -213.50 Mn |
| 10 | TransMedics | 3.18 Bn | 2.71 Bn | 113.20 Mn | 970,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 970,000.00 |
| Jun 30, 2026 | 970,000.00 |
| Mar 31, 2026 | 3.76 Mn |
| Mar 31, 2026 | 3.76 Mn |
| Dec 31, 2025 | 3.10 Mn |
| Dec 31, 2025 | 3.10 Mn |
| Sep 30, 2025 | 3.64 Mn |
| Sep 30, 2025 | 3.64 Mn |
| Jun 30, 2025 | 7.09 Mn |
| Jun 30, 2025 | 7.09 Mn |
| Mar 31, 2025 | 3.03 Mn |
| Mar 31, 2025 | 3.03 Mn |
| Dec 31, 2024 | 1.19 Mn |
| Dec 31, 2024 | 1.19 Mn |
| Sep 30, 2024 | 7.86 Mn |
| Sep 30, 2024 | 7.86 Mn |
| Jun 30, 2024 | 10.64 Mn |
| Jun 30, 2024 | 10.64 Mn |
| Mar 31, 2024 | 3.19 Mn |
| Mar 31, 2024 | 3.19 Mn |